1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Cresco Labs Inc.
  6. Financials
    CRLBF   CA22587M1068

CRESCO LABS INC.

(CRLBF)
  Report
Delayed OTC Markets  -  01:17 2022-08-10 pm EDT
3.545 USD   +0.42%
08/09Cresco Labs - Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs' SEED Initiative
AQ
08/08Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs' SEED™ Initiative
BU
08/01Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 9402 3431 9291 083--
Enterprise Value (EV)2 8912 3912 1911 4671 3921 266
P/E ratio -17,2x-25,6x-5,50x-124x32,2x12,1x
Yield ------
Capitalization / Revenue 7,31x4,92x2,35x1,20x0,97x0,69x
EV / Revenue 6,93x5,02x2,67x1,63x1,24x0,80x
EV / EBITDA 112x20,6x11,3x6,69x4,71x3,03x
Price to Book 4,04x3,66x2,33x1,34x1,23x1,10x
Nbr of stocks (in thousands) 136 840237 757290 734304 588--
Reference price (CAD) 8,9312,68,394,584,584,58
Announcement Date 04/27/202003/25/202103/23/2022---
1 CAD in Million
2 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1294768229021 1191 578
EBITDA1 7,99116194219295417
Operating profit (EBIT)1 -34,355,8-217129229387
Operating Margin -26,7%11,7%-26,5%14,3%20,4%24,5%
Pre-Tax Profit (EBT)1 -50,87,16-25762,5167378
Net income1 -43,2-81,9-297-21,744,085,7
Net margin -33,6%-17,2%-36,1%-2,40%3,93%5,43%
EPS2 -0,52-0,49-1,52-0,040,140,38
Dividend per Share ------
Announcement Date 04/27/202003/25/202103/23/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 215218214218229239
EBITDA1 56,457,050,751,356,561,0
Operating profit (EBIT)1 -26415,620,330,234,939,8
Operating Margin -123%7,14%9,45%13,8%15,3%16,7%
Pre-Tax Profit (EBT)1 -27611,6-0,8715,118,922,7
Net income1 -271-11,9-23,7-0,56-0,145,95
Net margin -126%-5,47%-11,0%-0,26%-0,06%2,49%
EPS2 -1,26-0,04-0,12-0,01-0,02
Dividend per Share ------
Announcement Date 11/11/202103/23/202205/18/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 -48,2261385309183
Net Cash position1 49,1-----
Leverage (Debt / EBITDA) -6,15x0,42x1,35x1,75x1,05x0,44x
Free Cash Flow1 -117-89,1-79,42,04102-13,1
ROE (Net Profit / Equities) -7,48%-13,8%2,23%1,10%10,9%-
Shareholders' equity1 577593-13 306-1 971405-
ROA (Net Profit / Asset) -11,5%-5,39%0,91%0,50%5,70%-
Assets1 3741 519-32 626-4 337771-
Book Value Per Share2 2,213,433,603,413,734,18
Cash Flow per Share -0,30-0,06----
Capex1 91,778,393,987,071,3105
Capex / Sales 71,3%16,4%11,4%9,64%6,37%6,66%
Announcement Date 04/27/202003/25/202103/23/2022---
1 USD in Million
2 CAD
Previous periodNext period
Estimates
Key data
Capitalization (CAD) 1 395 012 998
Capitalization (USD) 1 082 748 369
Net sales (USD) 821 682 000
Number of employees 3 600
Sales / Employee (USD) 228 245
Free-Float 52,0%
Free-Float capitalization (CAD) 725 792 471
Free-Float capitalization (USD) 563 328 524
Avg. Exchange 20 sessions (USD) 1 590 273
Average Daily Capital Traded 0,11%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA